Publications:

GSTT2 Switches from a Homeostatic Antioxidant to a Cell-Cycle-Coupled Factor in Therapy-Resistant Esophageal Adenocarcinoma

Daysha Ferrer-Torres, Paramita Ray, Noah Etzioni, Max A. Hammer, Archismaan Ghosh, Meilan Liu, Vinay Jeeyar, Sachin Wani, Sunnie S. Kim, Benedetto Mungo, Stefan Marasligiller, Danielle Kim Turgeon, Jules Lin, Peter D.R. Higgins, Jason R. Spence, Kiran H. Lagisetty, David G. Beer, Dipankar Ray

Preprints 2026, 2026081955. https://doi.org/10.20944/preprints202608.1955.v1

Suspension-Based Human Esophagoids Recapitulate WNT2B-Dependent Regulation of Esophageal Basal Progenitors

(in review)

Noah Etzioni, Tristan Frum, Kelli Johnson, Andrea P. Álvarez-Maldonado, Helena M. Yllescas-Lopez, David E. Bayer, Zhiwei Xiao, Madeline K. Eiken, Claudia Loebel, Joshua H. Wu, Yu-Hwai Tsai, Angeline Wu, Charles J. Zhang, Michael K. Dame, Bhargav Gunuguntla, Ashley J Cuttitta, Hana Ho, Dominic J Tigani, Jonathan Sexton, Venkata S. Dasuri, Nicholas Makogonov, Amy E. O’Connell, Jason R. Spence, Daysha Ferrer-Torres
bioRxiv 2026.06.23.733451; doi: https://doi.org/10.64898/2026.06.23.733451

GRAIL1 stabilizes misfolded mutant p53 through a ubiquitin ligase-independent, chaperone regulatory function

P Ray, S Jaiswal, D Ferrer-Torres, Z Wang, D Nancarrow, M Curtin, ...

Molecular Cancer Research 22 (11), 996-1010, 2024.

IL-13–induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis

S Marella, A Sharma, V Ganesan, D Ferrer-Torres, JW Krempski, ...

Journal of Allergy and Clinical Immunology 152 (6), 1550-1568, 2023.

A human liver organoid screening platform for DILI risk prediction

CJ Zhang, SR Meyer, MJ O’Meara, S Huang, MM Capeling, ...

Journal of hepatology 78 (5), 998-1006, 2023.

Mapping the adult human esophagus in vivo and in vitro

D Ferrer-Torres, JH Wu, CJ Zhang, MA Hammer, MK Dame, A Wu, ...

Development 149 (20), dev200614, 2022.

UBCH5 family members differentially impact stabilization of mutant p53 via RNF128 Iso1 during Barrett’s progression to esophageal adenocarcinoma

P Ray, DJ Nancarrow, D Ferrer-Torres, Z Wang, M San Martinho, T Hinton, ...

Cellular and molecular gastroenterology and hepatology 13 (1), 129-149, 2022.

A multi-omics human liver organoid screening platform for DILI risk prediction

CJ Zhang, MJ O’Meara, SR Meyer, S Huang, MM Capeling, ...

bioRxiv, 457824, 2021.

In vitro models of the human esophagus reveal ancestrally diverse response to injury

D Ferrer-Torres, JH Wu, CJ Zhang, MA Hammer, M Dame, A Wu, ...

bioRxiv, 2021.05. 20.444920, 2021.

Immune determinants of Barrett’s progression to esophageal adenocarcinoma

KH Lagisetty, DP McEwen, DJ Nancarrow, JG Schiebel, D Ferrer-Torres, ...

JCI insight 6 (1), e143888, 2021.

Modeling the Human Esophagus In Vitro to Understand Racial Disparities in the Tissue Response to Carcinogens.

D Ferrer-Torres, M Hammer, J Wu, A Wu, CJ Zhang, K Karpoff, ...

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL 56 (SUPPL 1), 2-3, 2020.

Isoforms of RNF128 regulate the stability of mutant P53 in Barrett's esophageal cells

D Ray, P Ray, D Ferrer-Torres, Z Wang, D Nancarrow, H Yoon, ...

Gastroenterology 158 (3), 583-597. e1, 2020.

Constitutively higher level of GSTT2 in esophageal tissues from African Americans protects cells against DNA damage

D Ferrer-Torres, DJ Nancarrow, H Steinberg, Z Wang, R Kuick, KM Weh, ...

Gastroenterology 156 (5), 1404-1415, 2019.

Generation of lung organoids from human pluripotent stem cells in vitro

AJ Miller, BR Dye, D Ferrer-Torres, DR Hill, AW Overeem, LD Shea, ...

Nature protocols 14 (2), 518-540, 2019.

Generation of human pluripotent stem cell-derived bud tip progenitor organoids

AJ Miller, Q Yu, BR Dye, D Ferrer-Torres, DR Hill, AW Overeem, LD Shea

Investigation of Epithelial Cell Fate Decisions in the Developing Human Lung, 2019.

Integrated genomic characterization of oesophageal carcinoma

Cancer Genome Atlas Research Network

Nature 541 (7636), 169, 2017.

Molecular Characterization of Esophageal Adenocarcinomas and Factors Influencing Racial Differences in Incidence

D Ferrer-Torres, 2017.

D Ferrer-Torres, DJ Nancarrow, R Kuick, DG Thomas, E Nadal, J Lin, ...

Oncotarget 7 (34), 54867, 2016.

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

Y Shen, R Upadhyayula, S Cevallos, RJ Messick, T Hsia, MP Leese, ...

British Journal of Cancer 113 (8), 1158-1167, 2015.

Paired exome analysis of Barrett's esophagus and adenocarcinoma

MD Stachler, A Taylor-Weiner, S Peng, A McKenna, AT Agoston, ...

Nature genetics 47 (9), 1047-1055, 2015.

The functional role of insulin-like growth factor binding protein-2 in esophageal adenocarcinoma chemoresistance

AL Myers, L Lin, DJ Nancarrow, Z Wang, D Ferrer-Torres, DG Beer, ...

Cancer Research 75 (15_Supplement), 4440-4440, 2015.

D Ferrer-Torres, D Nancarrow, R Kuick, E Nadal, TD Wang, A Chang, ...

Cancer Research 75 (15_Supplement), 2189-2189, 2015.